Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

AIM ImmunoTech Inc. Common Stock (NY:AIM)

0.2736 -0.0100 (-3.53%)
Streaming Delayed Price Updated: 3:04 PM EDT, Aug 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about AIM ImmunoTech Inc. Common Stock

< Previous 1 2 3 4 5 6 7 Next >
News headline image
AIM ImmunoTech Announces Cash Conservation Plan
From AIM ImmunoTech Inc.
Via Business Wire
News headline image
AIM ImmunoTech Issues Presentation Detailing Case for Re-Electing Current Directors to Oversee Continued Momentum and Drive Strategy to Create Long-Term Value for Patients and Shareholders
From AIM ImmunoTech Inc.
Via Business Wire
News headline image
Earnings Scheduled For November 15, 2024 ↗
 
Via Benzinga
News headline image
Insights into AIM ImmunoTech's Upcoming Earnings ↗
 
Via Benzinga
News headline image
Exploring AIM ImmunoTech's Earnings Expectations ↗
 
Via Benzinga
News headline image
AIM Stock Earnings: AIM ImmunoTech Misses EPS for Q1 2024 ↗
AIM stock results show that AIM ImmunoTech missed analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
News headline image
Preview: AIM ImmunoTech's Earnings ↗
 
Via Benzinga
News headline image
Preview: AIM ImmunoTech's Earnings ↗
 
Via Benzinga
News headline image
AIM ImmunoTech Files Definitive Proxy Statement and Sends Letter to Shareholders
From AIM ImmunoTech Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
 
Via Benzinga
News headline image
AIM Stock Earnings: AIM ImmunoTech Beats EPS, Beats Revenue for Q2 2024 ↗
AIM stock results show that AIM ImmunoTech beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
News headline image
AIM Stock Earnings: AIM ImmunoTech Misses EPS, Beats Revenue for Q4 2023 ↗
AIM stock results show that AIM ImmunoTech missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023. 
Via InvestorPlace
News headline image
Earnings Scheduled For April 2, 2024 ↗
Companies Reporting Before The Bell • Ocugen (NASDAQ:OCGN) is estimated to report earnings for its fourth quarter. 
Via Benzinga
News headline image
Earnings Scheduled For March 26, 2024 ↗
Companies Reporting Before The Bell • bluebird bio (NASDAQ:BLUE) is likely to report quarterly loss at $0.66 per share on revenue of $16.68 million. 
Via Benzinga
News headline image
AIM ImmunoTech And 3 Other Stocks Under $3 Insiders Are Buying ↗
The Dow Jones index closed lower by over 300 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
Via Benzinga
Topics Stocks
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗
Pre-market stock movers are worth checking out on Tuesday to catch up on all of the hottest stock market news for this morning! 
Via InvestorPlace
News headline image
AIM Shareholders Elect All Four Company Director Nominees at 2023 Annual Meeting
From AIM ImmunoTech Inc.
Via Business Wire
News headline image
Delaware Court Rules in Favor of AIM ImmunoTech and Upholds Board’s Determination that Activist Group’s Nominations Are Invalid
From AIM ImmunoTech Inc.
Via Business Wire
News headline image
AIM ImmunoTech Provides Update Regarding Annual Meeting
From AIM ImmunoTech Inc.
Via Business Wire
News headline image
AIM ImmunoTech And 3 Other Stocks Under $1 Insiders Are Buying ↗
The Dow Jones closed lower by over 50 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested... 
Via Benzinga
Topics Stocks
News headline image
AIM ImmunoTech Files Definitive Proxy Statement and Sends Letter to Shareholders
From AIM ImmunoTech Inc.
Via Business Wire
News headline image
NetSol Technologies And 2 Other Stocks Under $2 Insiders Are Buying ↗
The Dow Jones closed lower by more than 150 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
Via Benzinga
Topics Stocks
News headline image
Why Is Cancer Focused Microcap Stock AIM ImmunoTech Trading Higher Today? ↗
AIM ImmunoTech Inc (NYSE: AIM) announced that Roswell Park Comprehensive Cancer Center has reported the complete topline data from its Phase 1 study evaluating Ampligen (rintatolimod) as a component of... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
 
Via Benzinga
News headline image
Why AMC Entertainment Shares Are Trading Lower By 21%; Here Are 20 Stocks Moving Premarket ↗
Gainers BioNexus Gene Lab Corp. (NASDAQ: BGLC) shares gained 48.5% to $2.05 in pre-market trading after jumping 30% on Tuesday. 
Via Benzinga
News headline image
AIM ImmunoTech Rejects Director Nomination Notice from Activist Group Due to Numerous Material Defects, Omissions and False and Misleading Statements
From AIM ImmunoTech Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.